"In fact, women had a nearly identical increase in risk of COPD for every 10 pack-years of cigarette use when compared with ...

A new study reveals women are nearly 50 per cent more likely to develop COPD than men, despite smoking less. Published in BMJ ...

Summer brings unique challenges for patients with COPD. Learn how rising temperatures and humidity affect symptoms and what ...

Women often face delayed diagnosis or even misdiagnosis of various medical issues. Studies haves shown COPD affects women a ...

Asthma and COPD are conditions that need timely treatment. Promoting greater awareness of respiratory diseases, encouraging ...

One surprising finding was that many women with COPD had never smoked cigarettes—26.5% of women with COPD had never smoked, ...

COPD cases are rising in women. Uncover the latest insights to enhance diagnosis and treatment in your women patients.

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. | GSK had expected to secure an FDA ...

Women who have never smoked are around 50% more likely than their male counterparts to develop chronic obstructive pulmonary ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD ...